Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001240423 | SCV001413364 | uncertain significance | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2021-08-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with lysine at codon 93 of the ACADM protein (p.Glu93Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs752612962, ExAC 0.003%). This missense change has been observed in individual(s) with a positive newborn screening result for ACADM-related disease (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001240423 | SCV002092815 | uncertain significance | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2018-08-21 | no assertion criteria provided | clinical testing |